Welcome to COMPPARE
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer
Recent news
COMPPARE Enrolls 1,500th Proton Patient, Reaches…
The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for…
COMPPARE Achieves 75% Enrollment Milestone
The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable…
From Principles to Practice: Building…
On November 17, Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, participated in a…
For participants
About COMPPARE
Study goals, benefits, and other details
Locations
More than 45 partner sites across the US
Meet the Team
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Consortium Materials
Study-specific materials and other information.
ClinicalTrials.gov
Privately and publicly funded clinical studies conducted around the world.
VTOC Login
Medical Team sign-in page